Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for Ecologic Function in Pediatric Acquired Brain Injury
NCT02227056Phase 2Completed
- Sponsor
- Loewenstein Rehabilitation Hospital
- Start
- Jan 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Loewenstein Rehabilitation Hospital. Primary endpoints: Time to complete ecologic tasks at 3 weeks and Amount of assistance needed at 3 weeks. Started Jan 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02227056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227056.